Expected population impacts of discontinued prostate‐specific antigen screening

201497 citationsJournal Articlebronze Open Access

Authors

Roman Gulati · Fred Hutch Cancer Center

Alex Tsodikov · University of Michigan–Ann Arbor

Ruth Etzioni · Fred Hutch Cancer Center

Rachel Hunter‐Merrill · Fred Hutch Cancer Center

John L. Gore · University of Washington

Angela B. Mariotto · National Cancer Institute

Matthew R. Cooperberg

Abstract

Discontinuing PSA screening for all men may generate many avoidable cancer deaths. Continuing PSA screening for men aged <70 years could prevent greater than one-half of these avoidable cancer deaths while dramatically reducing overdiagnoses compared with continued PSA screening for all ages.

Topics & Keywords

Prostate Cancer Diagnosis and Treatment Prostate Cancer Treatment and Research Global Cancer Incidence and Screening

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cancer

Volume 120, Issue 22, pp. 3519-3526

DOI: 10.1002/cncr.28932

Field-Weighted Citation Impact: 11.08